open access

Vol 58, No 1 (2007)
Original papers
Published online: 2007-01-31
Submitted: 2013-02-15
Get Citation

The histopathological evaluation of the local tolerance of alendronate containing medicines

Zenon Jastrzębski, Luiza Napiórkowska, Roman Pykało
Endokrynologia Polska 2007;58(1):11-17.

open access

Vol 58, No 1 (2007)
Original papers
Published online: 2007-01-31
Submitted: 2013-02-15

Abstract


Introduction: In order to be effective, treatment for osteoporosis must be long-term. Unfortunately, according to clinical trials and clinical practice the most frequent cause of patient resignation from the treatment is adverse reactions to the medications. In the case of bisphosphonates they are most frequently connected with irritant impact of the drug on gastrointestinal mucosa. The aim of our study was to answer the question whether alendronate tablets coated with a thin neutral layer may protect gastrointestinal mucosa from the irritant effects of the active substance.
Material and methods: Three types of tablets were administered into the cheek pouches of 18 Syrian hamsters (divided into 3 experimental groups: I, II, III) i.e. regular alendronate tablets, coated alendronate tablets and placebo. The tablets were applied for 4 minutes a day on 4 consecutive days. 24 hours after the last application, the animals were sacrificed and segments of buccal tissue were taken for histopathological examination. Oral tissue reaction was assessed using the microscopic examination grading system developed by ISO. The following adverse changes of the tissue were recorded: epithelial lesions, leucocyte infiltration, vascular congestion and oedema. Later the irritation index was calculated.
Results: The irritation index was 11.0 (moderately irritant), 0.0 and 0.0 (none-irritant), in each group respectively.
Conclusion: It appears that the administration of the coated alendronate tablets reduces the frequency and intensity of the local adverse events from the gastrointestinal tract.

Abstract


Introduction: In order to be effective, treatment for osteoporosis must be long-term. Unfortunately, according to clinical trials and clinical practice the most frequent cause of patient resignation from the treatment is adverse reactions to the medications. In the case of bisphosphonates they are most frequently connected with irritant impact of the drug on gastrointestinal mucosa. The aim of our study was to answer the question whether alendronate tablets coated with a thin neutral layer may protect gastrointestinal mucosa from the irritant effects of the active substance.
Material and methods: Three types of tablets were administered into the cheek pouches of 18 Syrian hamsters (divided into 3 experimental groups: I, II, III) i.e. regular alendronate tablets, coated alendronate tablets and placebo. The tablets were applied for 4 minutes a day on 4 consecutive days. 24 hours after the last application, the animals were sacrificed and segments of buccal tissue were taken for histopathological examination. Oral tissue reaction was assessed using the microscopic examination grading system developed by ISO. The following adverse changes of the tissue were recorded: epithelial lesions, leucocyte infiltration, vascular congestion and oedema. Later the irritation index was calculated.
Results: The irritation index was 11.0 (moderately irritant), 0.0 and 0.0 (none-irritant), in each group respectively.
Conclusion: It appears that the administration of the coated alendronate tablets reduces the frequency and intensity of the local adverse events from the gastrointestinal tract.
Get Citation

Keywords

osteoporosis; alendronate; coated tablets

About this article
Title

The histopathological evaluation of the local tolerance of alendronate containing medicines

Journal

Endokrynologia Polska

Issue

Vol 58, No 1 (2007)

Pages

11-17

Published online

2007-01-31

Bibliographic record

Endokrynologia Polska 2007;58(1):11-17.

Keywords

osteoporosis
alendronate
coated tablets

Authors

Zenon Jastrzębski
Luiza Napiórkowska
Roman Pykało

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl